Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/35259

Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry

Título :
Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry
Autor :
Balaz, David
Wikman-Jorgensen, Philip Erick  
Giner Galvañ, Vicente
Rubio-Rivas, Manuel  
de Miguel-Campo, Borja  
Noureddine López, Mariam  
López Caleya, Juan Francisco  
Gómez Huelgas, Ricardo  
Pesqueira Fontán, Paula María
Méndez Bailón, Manuel
Fernández-Garcés, Mar  
Fernádez-Cruz, Ana
García García, Gema María
Rhyman, Nicolás
Corral-Gudino, Luis  
Editor :
MDPI
Departamento:
Departamentos de la UMH::Medicina Clínica
Fecha de publicación:
2021-10-08
URI :
https://hdl.handle.net/11000/35259
Resumen :
Objectives: Since the results of the RECOVERY trial, WHO recommendations about the use of corticosteroids (CTs) in COVID-19 have changed. The aim of the study is to analyse the evolutive use of CTs in Spain during the pandemic to assess the potential influence of new recommendations. Material and m...  Ver más
Palabras clave/Materias:
COVID-19
corticosteroids
Spain
comorbidities
Tipo de documento :
info:eu-repo/semantics/article
Derechos de acceso:
info:eu-repo/semantics/openAccess
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
DOI :
10.3390/jcm10194610
Publicado en:
J Clin Med . 2021 Oct 8;10(19):4610
Aparece en las colecciones:
Artículos Medicina Clínica



Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.